New study with Medical University of Innsbruck validates Attana Virus Analytics (AVA™) for SARS-CoV-2 diagnostics
In a new study conducted by Attana and Medical University of Innsbruck, a number of individuals have been tested for COVID-19 with both AVA[TM] and EUROIMMUN’s ELISA-based technology. The results show that Attana’s technology accurately measures the concentration of SARS-CoV-2 antibodies with at least the precision of current FDA-approved technology.Description of results The Medical University of Innsbruck delivered samples from 6 different individuals in Austria, on which Attana performed analyses using the AVA platform. All samples have also undergone tests for SARS-CoV-2 spike-